市場調查報告書
商品編碼
1447121
到 2030 年安瓿和泡殼包裝市場預測:按包裝類型、材料、最終用戶和地區進行的全球分析Ampoules and Blister Packaging Market Forecasts to 2030 - Global Analysis By Packaging Type (Ampoules and Blister), By Material (Plastic, Glass, Aluminium and Other Materials), End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球安瓿和泡殼包裝市場規模為 141 億美元,預計在預測期內將以 7.3% 的年複合成長率成長,到 2030 年達到 231 億美元。
安瓿是小型密封管瓶,用於封裝和儲存單劑量的液體藥物。泡殼包裝由塑膠片或鋁片組成,每個泡殼包含單劑量的產品。兩種包裝方法均可確保劑量準確、保護藥物免受外部影響並維持產品完整性。
根據《2018年能源展望》,65歲及以上人口比例預計將從2016年的10%以上增加到2025年的14%以上。
對防篡改包裝的需求增加
對防篡改包裝的需求不斷成長是安瓿和泡殼包裝市場的關鍵促進因素。砸道機篡改功能透過指示包裝是否已開啟或損壞,為消費者提供產品完整性的保證。在醫學和醫療保健領域,這對於確保藥物的安全性和有效性至關重要。隨著人們對產品安全性和真實性的擔憂不斷增加,安瓿和泡殼包裝擴大採用砸道機篡改包裝,以滿足消費者的期望和監管要求。
監管挑戰
有關藥品包裝的嚴格法規要求遵守有關安全、標籤和品質保證的特定標準。滿足多樣化的國際合規要求既複雜又耗時,這可能會影響產品開發時間表並增加營運成本。此外,不斷變化的監管條件可能需要不斷調整包裝方法。此外,保持合規性變得至關重要,並且限制了設計和材料的彈性。
藥品需求增加
製藥業的擴張增加了對可靠、高效的包裝解決方案的需求,以確保藥品的安全性和完整性。安瓿或泡殼包裝可實現安全、準確的劑量,同時保護產品免受外部因素的影響。對這些包裝解決方案不斷成長的需求正在推動市場參與者參與不斷擴大的製藥行業,推動行業成長和創新。
環境友好和永續包裝
隨著人們對環境問題的認知不斷增強,對環保替代品的需求也不斷增加。塑膠和鋁等傳統包裝材料會導致環境惡化。安瓿和泡殼包裝產業必須透過開發減少廢棄物和碳足跡的永續解決方案來適應具有環保意識的消費者偏好。如果無法解決這些問題,可能會導致市場佔有率下降並阻礙市場成長。
COVID-19 大流行加速了對藥品的需求,從而影響了安瓿和泡殼包裝市場。人們對醫療保健和疫苗分發的日益關注增加了對安全高效包裝解決方案的需求。為了應對大流行帶來的挑戰,該行業經歷了優先事項和生產需求的轉變,其中一個顯著的重點是確保基本藥物的安全可靠的包裝。
預計鋁業在預測期內將成為最大的行業
由於鋁材具有優異的阻隔性能、重量輕和可回收性,預計在預測期內將主導安瓿和泡殼包裝市場。鋁包裝有效地防止外部因素的影響,並確保藥品的完整性。此外,其永續性符合世界對環保包裝解決方案日益重視的趨勢。這些因素使鋁成為安瓿和泡殼包裝市場的首選材料。
預計製藥和醫療保健產業在預測期內的年複合成長率最高
預計在預測期內,製藥和醫療保健領域的安瓿和泡殼包裝市場將實現最高成長。這一成長的推動因素包括全球藥品需求的增加、對醫療保健基礎設施的日益關注以及對安全高效包裝解決方案的需求。安瓿和泡殼包裝在藥品儲存和運輸中的重要作用有助於該細分市場的持續成長和突出。
在強勁的製藥業、先進的醫療基礎設施以及對研發的高度重視的推動下,北美預計將引領安瓿和泡殼包裝市場。該地區嚴格的監管標準確保了對安全、合規的包裝解決方案的需求。此外,對病人安全的日益重視、創新的給藥系統和成熟的製造業也有助於北美的領先地位。該地區的經濟實力和對技術進步的承諾進一步鞏固了其作為市場主要參與者的地位。
由於製藥和醫療保健行業的擴張、人口的成長和可支配收入的增加,亞太地區是安瓿和泡殼包裝市場成長率最高的地區。該地區的製藥業正在經歷顯著成長,推動了對安全高效包裝解決方案的需求。此外,政府舉措、技術進步和蓬勃發展的電子商務產業正在加速安瓿和泡殼包裝的採用,使亞太地區成為預測期內的主要成長市場。
According to Stratistics MRC, the Global Ampoules and Blister Packaging Market is accounted for $14.1 billion in 2023 and is expected to reach $23.1 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Ampoules are small, sealed vials used to contain and preserve a single dose of a liquid medication. Blister packaging consists of a sheet of plastic or aluminum with individual compartments, or blisters, each holding a single dosage of a product. Both packaging methods ensure accurate dosage delivery and protect pharmaceuticals from external influences, maintaining product integrity.
According to the Energy Source Outlook 2018, the proportion of the population above 65 years of age is expected to cross 14% by the year 2025 from over 10% in 2016.
Increasing demand for tamper-evident packaging
The rising demand for tamper-evident packaging is a significant driver in the ampoules and blister packaging markets. Tamper-evident features provide consumers with assurance of product integrity by indicating if the packaging has been opened or compromised. In pharmaceuticals and healthcare, this is crucial for ensuring the safety and effectiveness of medications. As concerns about product security and authenticity grow, the adoption of tamper-evident packaging in ampoules and blister packaging is increasing to meet consumer expectations and regulatory requirements.
Regulatory challenges
Stringent regulations governing pharmaceutical packaging demand adherence to specific standards for safety, labeling, and quality assurance. Meeting diverse international compliance requirements can be complex and time-consuming, impacting product development timelines and increasing operational costs. Additionally, evolving regulatory landscapes may necessitate constant adjustments to packaging practices. Moreover, maintaining compliance becomes a crucial aspect, limiting flexibility in design and materials.
Increasing demand for pharmaceutical products
Due to the expansion of the pharmaceutical industry globally, there is a growing need for reliable and efficient packaging solutions to ensure the safety and integrity of medications. Ampoules and blister packaging offer secure and precise dosing while protecting products from external factors. The increasing demand for these packaging solutions positions market players to capitalize on the expanding pharmaceutical sector, fostering growth and innovation in the industry.
Environmental concerns and sustainable packaging
With heightened awareness of ecological issues, there's a growing demand for eco-friendly alternatives. Traditional packaging materials, such as plastic and aluminum, contribute to environmental degradation. The ampoules and blister packaging industry must adapt to eco-conscious consumer preferences by developing sustainable solutions that reduce waste and carbon footprints. Failure to address these concerns may lead to market share loss which hinders market growth.
The COVID-19 pandemic has influenced the ampoules and blister packaging market by accelerating the demand for pharmaceutical products. Increased focus on healthcare and vaccine distribution has heightened the need for secure and efficient packaging solutions. The industry has experienced shifts in priorities and production demands to meet the challenges posed by the pandemic, with a notable emphasis on ensuring the safe and reliable packaging of essential pharmaceuticals.
The aluminium segment is expected to be the largest during the forecast period
The aluminum segment is anticipated to dominate the ampoules and blister packaging market during the forecast period due to its exceptional barrier properties, lightweight nature, and recyclability. Aluminum packaging offers effective protection against external factors, ensuring the integrity of pharmaceutical products. Additionally, its sustainability aligns with the increasing global emphasis on eco-friendly packaging solutions. These factors contribute to the continued prominence of the aluminum segment, making it a preferred material in the ampoules and blister packaging market.
The pharmaceuticals and healthcare segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals and healthcare segment is projected to achieve the highest growth in the ampoules and blister packaging market during the forecast period. This growth is driven by the rising global demand for pharmaceutical products, the increased focus on healthcare infrastructure, and the need for secure and efficient packaging solutions. The critical role of ampoules and blister packaging in preserving and delivering medications contributes to the sustained growth and prominence of this segment in the market.
North America is poised to lead the ampoules and blister packaging market, fueled by a robust pharmaceutical industry, advanced healthcare infrastructure, and a strong focus on research and development. The region's stringent regulatory standards ensure the demand for secure and compliant packaging solutions. Additionally, a growing emphasis on patient safety, innovative drug delivery systems, and a well-established manufacturing sector contribute to North America's leadership. The region's economic strength and commitment to technological advancements further solidify its position as a key player in the market.
Asia Pacific is poised for the highest growth rate in the ampoules and blister packaging market due to expanding pharmaceutical and healthcare sectors, an increasing population and rising disposable incomes. The region's pharmaceutical industry is witnessing significant growth, driving the demand for secure and efficient packaging solutions. Additionally, government initiatives, technological advancements, and a burgeoning e-commerce sector contribute to the accelerated adoption of ampoules and blister packaging, making Asia Pacific a key growth market in the forecast period.
Key players in the market
Some of the key players in Ampoules and Blister Packaging Marketinclude Amcor Limited, AptarGroup, Inc., Becton, Dickinson and Company (BD), Constantia Flexibles Group GmbH, Gerresheimer AG, Intrapac International Corporation, Klockner Pentaplast Group, Kuraray Co., Ltd., MeadWestvaco Corporation, Nipro Corporation, Romaco Noack , RPC Group Plc, SCHOTT AG, Sonoco Products Company, West Pharmaceutical Services, Inc., WestRock Company and Wipak Group.
In January 2024, Kuraray Europe GmbH (KEG) (a 100% owned subsidiary of Kuraray Co., Ltd.; Headquarters: Frankfurt, Germany; President: Dr. Matthias Gutweiler; hereinafter "KEG") announces the establishment of a new European subsidiary, Kuraray Europe Spain S.L., to reinforce KEG's networks in Europe and accelerate future market development in the Iberian Peninsula.
In December 2023, Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced the opening of its new Aptar Mumbai site, which will increase manufacturing capabilities in South East Asia.
In January 2023, Romaco Noack introduced the Unity 600 blister packaging line, offering improved sustainability, process reliability, and performance. The monobloc features an innovative transfer unit for enhanced traceability and format flexibility. With a maximum output of 600 blisters and 350 cartons per minute, the line achieves high-speed production.